Beta cell therapies for type 1 diabetes

Dr. Thompson's Lab published a study on different Beta Cells dysfunction and their respective therapeutic targets in preventing Type 1 Diabetes: "We discuss opportunities and important open questions around the effectiveness of beta cell therapies and challenges for clinical utility. We further evaluate ways in which beta cell drug therapy could be combined with immunotherapy for preventing T1D in light of our growing appreciation of disease heterogeneity and patient endotypes."

CLICK HERE for the full article